Navigation Links
Pathwork Diagnostics Announces Key Additions to Management Team
Date:10/8/2008

CFO and VP of US Sales Bring Industry Expertise to Pathwork Following FDA

Clearance and $20M Fundraising Round

SUNNYVALE, Calif., Oct. 8 /PRNewswire/ -- Pathwork Diagnostics, a molecular diagnostics company focused on oncology, announced today the appointment of two key positions within the company's management team, Fletcher Payne as Chief Financial Officer and Mark McDonough as Vice President of US Sales. These professionals bring over 20 years of industry expertise in their respective positions to Pathwork.

"Having Fletcher and Mark on the Pathwork management team will be a great asset moving forward," said Deborah J. Neff, President and Chief Executive Officer of Pathwork Diagnostics. "Both have proven track records in helping emerging companies grow efficiently and achieve results."

Pathwork's new CFO, Fletcher Payne, a graduate of UC Berkeley's Haas School of Business with a BS in Business Administration, joins Pathwork from Plexxikon Inc., a biopharmaceutical company where he served as a VP and CFO. Payne will lead the financial team, implement processes to support commercial growth and develop the overall financial strategy. Payne has over 20 years of business and financial experience, in both start-up and Fortune 500 companies. Prior to Plexxikon, he worked for Rinat Neuroscience, Dynavax Technologies, Cell Genesys, Sun Microsystems and IBM.

Mark McDonough joins Pathwork as Vice President of US Sales from US LABS, a division of Laboratory Corporation of America. With over 10 years of cancer diagnostics and reference laboratory experience, Mark will be responsible for the strategic and tactical sales initiatives at Pathwork. Prior to his time at US LABS, McDonough held various sales and sales management roles at Ventana Medical Systems and served as a Navigator and Communications Officer in the United States Navy. McDonough is a graduate of Miami University of Ohio with a BS in Finance.

About Pathw
'/>"/>

SOURCE Pathwork Diagnostics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Pathwork Diagnostics Closes $20M Financing
2. Pathwork(R) Diagnostics Launches Genomics-Based Test For Hard-To-Identify Tumors Through Its CLIA-Certified Laboratory
3. Virginia Commonwealth University to Study Genomics-Based Diagnostic Test: Pathwork Diagnostics Tissue of Origin Test Designed to Aid in Determination of a Tumors Origin
4. InformationWeek Puts Roche Diagnostics on Top 500 Innovative Tech Users List
5. Fujirebio Diagnostics Named One of the Best Places to Work in Pennsylvania
6. Genetic Engineering & Biotechnology News reports on growing role of molecular diagnostics
7. Exiqon A/S Today Announces a Grant of License to Roche Diagnostics
8. Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecker to Board
9. MediCult Acquires US-Based MidAtlantic Diagnostics to Further Strengthen ART Presence
10. Enigma Diagnostics Announces an Award of GBP 1.8 Million From UK Government
11. Inverness Medical Innovations to Attend the Goldman Sachs Diagnostics Conference on September 18, 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., Dec. 2 Martek Bioscien...hat it intends to release the results of its fourt...9, at approximately 4:00 p.m. Eastern Time (ET). ... conduct a conference call to discuss these result...en to the call live via webcast by visiting Martek...
(Date:12/2/2009)... Dec. 2 Reportlinker.com announces... its catalogue: ,, Neurostimulation - A Global...r.com/p0164232/Neurostimulation---A-Global-Market-...n market stands enthused by the growing base of ag...ted diseases such as, Parkinson,s, and Alzheimer,s...
(Date:12/2/2009)... Dec. 2 Reportlinker.com announces... its catalogue: ,, Drug Discovery Technologies...ities ,, http://www.reportlinker.com/p0164246...Market-Trends--Opportunities.html ,, Drug disc...f every pharmaceutical company,s business strategy...
(Date:12/2/2009)...c. 2 The world,s first concept dem...y, a breakthrough alternative to replace a petroch... synthetic rubber with renewable biomass, made the...re will be on display at a lounge in the common de...rt throughout December 21, while the other tire wi...
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 8Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities 9The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3
...nce,Authority has launched a $2.5 million initiati...ate products that protect Americans from the,inten... national economy or,to infect humans., The goals...tiative,(CBRI) are to support interinstitutional r...n-animal diseases; (2) provide advanced test and,e...
... 13th Annual Healthcare Conference, SAN DIEGO, Ja...ice company focused on the treatment of cardiac,ar...ts Cardiac Cryoablation,System and its next genera...ial Fibrillation Symposium, January 17-19, 2008. C...In August 2007, the FDA approved the Cryoablation ...
...the,Federal Drug Administration,s announcement tod... for human consumption, Smithfield Foods, Inc.,(NY...company is not planning,to produce meat products f...g animals is relatively new. As thoughtful leaders...er scientific research on this technology., Throu...
Other Biology Technology:Collaborative Biosecurity Research Initiative Launched to Target Animal and Public Health Threats Nationally 2Collaborative Biosecurity Research Initiative Launched to Target Animal and Public Health Threats Nationally 3CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium 2CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium 3
(Date:12/2/2009)...HILADELPHIA Mexican-American adolescents exposed ...ely to pick up the habit themselves, and this may ...th smoking initiation, according to new study find...ing in the United States and highlights the global...ramework Convention on Tobacco Control, which incl...
(Date:12/2/2009)...LADELPHIA Assurance of a cancer-free status did n...uterized tomography (CT) lung-cancer screening pro...s wrote in a study published in Cancer Epidemiolo...rican Association for Cancer Research. The Decembe...hese findings should negate widespread concern in ...
(Date:12/2/2009)...ecalls of ground beef, peanut butter, and other fo... concern about food safety. They also are quietly ...pment and fostering new food safety regulations. T... current issue of Chemical & Engineering News , (... Editor Jyllian Kemsley and Senior Correspondent M...
Breaking Biology News(10 mins):Watching movies featuring characters who smoke negatively influences Mexican-American teens 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2Only Five States Have Plans to Address the Health Impact of Climate Change New Report Finds 60093 1Only Five States Have Plans to Address the Health Impact of Climate Change New Report Finds 60093 2Only Five States Have Plans to Address the Health Impact of Climate Change New Report Finds 60093 3Only Five States Have Plans to Address the Health Impact of Climate Change New Report Finds 60093 4American College of Cardiology Launches the Nations First Registry Based Cardiovascular Practice Network 5700 1American College of Cardiology Launches the Nations First Registry Based Cardiovascular Practice Network 5700 2American College of Cardiology Launches the Nations First Registry Based Cardiovascular Practice Network 5700 3New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 1New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 2New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 3New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 4New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 5New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 6New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 7New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 8New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 9New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 10
...gilent Technologies Inc. (NYSE: A) today announced...design, probe sequence and annotation information ...formation is expected to improve cross-laboratory ...arison. , "Full release of the probe sequences is ...to take," said Catherine Ball, president of the Mi...
...UHC researchers have defined genetic resistance to...mber of the viral group that causes some of the wo...cken pox and mononucleosis. The groundbreaking res...ides a roadmap for the development of human therap...atients and improve the success of transplant surg...
...he telltale paw prints with huge 10 centimetre-lon...ating DNA evidence seals the case of the most nort...els mounting evidence that Canada,s High Arctic is...Nanuk is having to make room for its southern cous...ear (Ursus arctos) was discovered on Melville Isla...
Other Biology News:Virus-host interactions at sea effect global photosynthesis 2MUHC scientists describe genetic resistance to rampant virus 2Grizzlies set to invade high Arctic? 2
Mouse Anti-Cig2 Monoclonal Antibody, Unconjugated, Clone CIG 3A11 / 5 from Abcam
Rabbit Anti-CD18, phospho (Ser756 / Thr758 / Thr759) Polyclonal Antibody, Unconjugated from Cell Signaling Technology
Goat Anti-Human SART1 Polyclonal Antibody, Unconjugated from Abcam
Anti-Cyclin D1, phospho (Thr286) Antibody, Unconjugated from Cell Signaling Technology
Biology Products: